Invitation to a webcast: adapting and acting in response to the Covid-19 crisis
20 April 2020
Our news
Bringing you the latest!
Investors
MedinCell has launched a COVID-19 research initiative based on its experience to formulate long-acting injectable Ivermectin
6 April 2020
MedinCell receives $ 6.4 million grant from Unitaid to fight Malaria
25 March 2020
MedinCell provides a portfolio update for J.P. Morgan Healthcare Conference 2020
13 January 2020
Publication of the activity report and financial information for the first half-year (April – Sept. 2019)
3 December 2019
MedinCell announces that mdc-CWM progresses as planned
27 September 2019
MedinCell receives a new grant to develop a best-in-class long-acting injectable product for HIV PrEP
5 September 2019
MedinCell partners to address the untapped financial potential in Animal Health
28 August 2019